entinostat (Syndax Inc)
86
Structured Review
Syndax Inc
entinostat
Entinostat, supplied by Syndax Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/entinostat/entinostat/us12655159-432-22-24
Average 86 stars, based on 1 article reviews
Entinostat, supplied by Syndax Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/entinostat/entinostat/us12655159-432-22-24
Average 86 stars, based on 1 article reviews
entinostat - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Western Blot:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: Transplantation Assay:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: RNA Sequencing:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: Expressing:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: Flow Cytometry:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: Co-Culture Assay:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: Single Cell:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: Isolation:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: Derivative Assay:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: Fluorescence:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: Magnetic Beads:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: Activation Assay:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: ChIP-sequencing:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: Live Cell Imaging:Article Title: Heterobifunctional compounds and their use in treating disease Article Snippet: Other HDAC inhibitors being studied which may be used in the present invention include Article Title: Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal. Article Snippet: We would like to thank Article Title: HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery Article Snippet: R.M.E. and M.D. are co-founders of Article Title: SMARCA degraders and uses thereof Article Snippet: In some embodiments, a CDK 4/6 inhibitor is selected from palbociclib (Ibrance, Pfizer); ribociclib (Kisqali, Novartis); abemaciclib (Ly2835219, Eli Lilly); and trilaciclib (G1T28, G1 Therapeutics). Article Title: A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells Article Snippet: Chemical inhibitors used in this study: |
